Grace Colón on Clubhouse
Bio
Former CEO at InCarda Therapeutics; Boards: CareDx (NASDAQ:CDNA); Voyager Therapeutics (NASDAQ:VYGR); MIT Corporation (MIT Board of Trustees); Biotechnology Innovation Organization (BIO); ProterixBio (Executive Chairman)
Biotechnology Executive, Board Member and Serial Entrepreneur; former VC Partner
Mom; wife; proud nerd; Latina (puertorriqueña)
Former Board member at Cocoon Biotech, PerceptiMed, Paradigm Diagnostics; formerly at Gilead, Affymetrix, New Science Ventures, Intrexon, McKinsey and Merck
Alum MIT and Penn (Chemical Engineering PhD/post-doc and BSE, respectively)
Therapeutics, diagnostics, digital health, medical devices, drug/device combinations, genomics, proteomics, microbiome, synbio, bioindustrials, greentech/cleantech
SCUBA, paddle boarding, running, yoga, musical theatre (watching and performing), sci-fi
https://www.linkedin.com/in/gracecolon/
Invited by: Peter Noymer
Last 10 Records
if the data has not been changed, no new rows will appear.
| Day | Followers | Gain | % Gain |
|---|---|---|---|
| June 12, 2024 | 2,454 | +5 | +0.3% |
| May 09, 2024 | 2,449 | +3 | +0.2% |
| March 24, 2024 | 2,446 | +4 | +0.2% |
| March 07, 2024 | 2,442 | +7 | +0.3% |
| February 14, 2024 | 2,435 | +7 | +0.3% |
| January 27, 2024 | 2,428 | +6 | +0.3% |
| January 10, 2024 | 2,422 | +13 | +0.6% |
| December 25, 2023 | 2,409 | +7 | +0.3% |
| December 10, 2023 | 2,402 | +6 | +0.3% |
| November 25, 2023 | 2,396 | -1 | -0.1% |
